Beta Bionics, Inc. (BBNX) Total Non-Current Liabilities (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Total Non-Current Liabilities data on file, last reported at $31.6 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 32.43% year-over-year to $31.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.6 million (up 32.43% YoY) and the FY2025 annual result came in at $39.6 million, up 37.77% from the prior year.
• Total Non-Current Liabilities fell to $31.6 million in Q1 2026 per BBNX's latest filing, from $39.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $39.6 million in Q4 2025, with the low at $23.9 million in Q1 2025.
• Average Total Non-Current Liabilities over 4 years is $30.6 million, with a median of $29.1 million recorded in 2023.
• Year-over-year, Total Non-Current Liabilities declined 1.3% in 2024 and soared 37.77% in 2025.
• Beta Bionics' Total Non-Current Liabilities stood at $29.1 million in 2023, then decreased by 1.3% to $28.7 million in 2024, then soared by 37.77% to $39.6 million in 2025, then fell by 20.14% to $31.6 million in 2026.
• Business Quant data shows BBNX's Total Non-Current Liabilities at $31.6 million in Q1 2026, $39.6 million in Q4 2025, and $34.1 million in Q3 2025.